< Browse more articles

More and more police forces at federal, provincial and local levels are equipping their officers with naloxone, the medication used to reverse the effects of opioid overdoses. But there remains confusion over how this lifesaving treatment can be administered.

Adapt Pharma Canada produces NARCAN® (naloxone HCl) Nasal Spray 4 mg, a brand name which is often used interchangeably and sometimes incorrectly to identify any form of naloxone. NARCAN® has sometimes been misidentified as the intramuscular injected naloxone administered with a needle or the needle-based naloxone treatment that has been retrofitted with nasal atomizers.

NARCAN® is a ready-to-use, needle-free device that does not require any assembly or medical training. While not a substitute for appropriate medical care, NARCAN® delivers a dose of 4mg of naloxone in a concentrated 0.1 ml spray to temporarily reverse an overdose in emergency situations.

Police departments across Canada continue to incorporate NARCAN® in response to the worsening crisis and the rise of illicit and lethal opioid drugs. More than 22,000 units have been shipped to more than 75 first responders, emergency healthcare officials and harm reduction sites nationwide, including all front-line RCMP officers, over the past several months.

“NARCAN® Nasal Spray was designed to be easily handled by non-medical personnel, including police officers, firefighters, and friends and family of overdose victims,” said David Renwick, General Manager, Adapt Pharma Canada. “It helps ensure that those who are often the first people on the scene of an overdose can deliver naloxone in a simple, quick and effective way.”